Adverum Biotechnologies, Inc.
ADVM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$131 | -$122 | -$155 | -$146 |
| Dep. & Amort. | $4 | $6 | $7 | $5 |
| Deferred Tax | $0 | $0 | $0 | $4 |
| Stock-Based Comp. | $14 | $18 | $20 | $25 |
| Change in WC | $1 | -$9 | $20 | $4 |
| Other Non-Cash | $20 | $17 | -$0 | -$0 |
| Operating Cash Flow | -$92 | -$91 | -$108 | -$108 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$12 | -$15 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$102 | -$37 | -$104 | -$408 |
| Inv. Sales/Matur. | $60 | $134 | $258 | $501 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$42 | $97 | $142 | $79 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$0 |
| Stock Issued | $119 | $0 | $1 | $2 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | -$0 | $0 | $1 |
| Financing Cash Flow | $120 | $0 | $1 | $2 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$14 | $6 | $34 | -$27 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $77 | $71 | $37 | $63 |
| End Cash | $63 | $77 | $71 | $37 |
| Free Cash Flow | -$93 | -$92 | -$120 | -$123 |